As of 2024-12-11, the Relative Valuation of Praxis Precision Medicines Inc (PRAX) is (225.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 69.90 USD, the upside of Praxis Precision Medicines Inc based on Relative Valuation is -422.2%.
The range of the Relative Valuation is (229.77) - (255.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 45.2x | 35.0x |
| Forward P/E multiples | 19.9x - 31.5x | 20.6x |
| Fair Price | (229.77) - (255.05) | (225.23) |
| Upside | -428.7% - -464.9% | -422.2% |
| Date | P/E |
| 2024-12-06 | -8.62 |
| 2024-12-05 | -8.41 |
| 2024-12-04 | -9.16 |
| 2024-12-03 | -8.90 |
| 2024-12-02 | -9.61 |
| 2024-11-29 | -9.90 |
| 2024-11-27 | -9.81 |
| 2024-11-26 | -9.83 |
| 2024-11-25 | -9.22 |
| 2024-11-22 | -9.20 |
| 2024-11-21 | -9.02 |
| 2024-11-20 | -9.09 |
| 2024-11-19 | -8.98 |
| 2024-11-18 | -8.83 |
| 2024-11-15 | -8.86 |
| 2024-11-14 | -9.49 |
| 2024-11-13 | -10.09 |
| 2024-11-12 | -10.24 |
| 2024-11-11 | -10.47 |
| 2024-11-08 | -9.61 |
| 2024-11-07 | -9.30 |
| 2024-11-06 | -8.87 |
| 2024-11-05 | -8.98 |
| 2024-11-04 | -8.64 |
| 2024-11-01 | -8.43 |
| 2024-10-31 | -8.64 |
| 2024-10-30 | -8.64 |
| 2024-10-29 | -8.77 |
| 2024-10-28 | -8.85 |
| 2024-10-25 | -8.83 |
| 2024-10-24 | -8.70 |
| 2024-10-23 | -8.94 |
| 2024-10-22 | -8.92 |
| 2024-10-21 | -9.03 |
| 2024-10-18 | -9.04 |
| 2024-10-17 | -9.25 |
| 2024-10-16 | -9.14 |
| 2024-10-15 | -8.89 |
| 2024-10-14 | -8.64 |
| 2024-10-11 | -8.02 |
| 2024-10-10 | -7.65 |
| 2024-10-09 | -7.78 |
| 2024-10-08 | -7.99 |
| 2024-10-07 | -7.71 |
| 2024-10-04 | -8.02 |
| 2024-10-03 | -8.18 |
| 2024-10-02 | -7.55 |
| 2024-10-01 | -7.09 |
| 2024-09-30 | -7.10 |
| 2024-09-27 | -7.14 |